Conferences \ Innovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing \ Agenda \ Sunitha Nagrath |
Register | Login |
Welcome and Introduction by Conference Co-Chairpersons -- Scope of the Conference and Topics CoveredMonday, 6 May 2024 at 09:00 Add to Calendar ▼2024-05-07 14:00:002024-05-07 15:00:00Europe/LondonThe Next Big Small Things: Technology Driven Approaches to Bring Extracellular Vesicles into the ClinicInnovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing in Ann Arbor, MichiganAnn Arbor, MichiganSELECTBIOenquiries@selectbiosciences.com Micro Innovations Defining the New Frontiers of Liquid BiopsyTuesday, 7 May 2024 at 09:30 Add to Calendar ▼2024-05-07 14:00:002024-05-07 15:00:00Europe/LondonThe Next Big Small Things: Technology Driven Approaches to Bring Extracellular Vesicles into the ClinicInnovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing in Ann Arbor, MichiganAnn Arbor, MichiganSELECTBIOenquiries@selectbiosciences.com Microfluidic technologies were always at the forefront of innovations in liquid biopsies. There were several corner stone microfluidic technologies that enabled sensitive and yet specific identification of blood-based biomarkers. The confluence of technology advancement and rapid developments in molecular characterization techniques pushed the boundaries of liquid biopsies thus enhancing the clinical utility of blood biopsies. Several such key enabling technologies will be presented. How isolation of circulating tumor cells using novel microfluidic technologies can enable precision diagnostics will be demonstrated with the example clinical case studies. The Next Big Small Things: Technology Driven Approaches to Bring Extracellular Vesicles into the ClinicTuesday, 7 May 2024 at 14:00 Add to Calendar ▼2024-05-07 14:00:002024-05-07 15:00:00Europe/LondonThe Next Big Small Things: Technology Driven Approaches to Bring Extracellular Vesicles into the ClinicInnovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing in Ann Arbor, MichiganAnn Arbor, MichiganSELECTBIOenquiries@selectbiosciences.com Small nanoscale extracellular vesicles (EVs), known as exosomes, represent a rapidly emerging biomarker for cancer detection by liquid biopsy. Given the tiny amount of cargo carried by these nano-sized vesicles, the development of techniques that can analyze these important carriers is an active area of research in recent times. Additionally, while high in information content, the current exosomes profiling protocols are lengthy, preventing their widespread utilization and cancer diagnostics in a timely manner. Recent advances in technologies and approaches will be discussed to isolate and probe exosomes. We present the isolation of tumor derived EVs and their molecular cargo for rapid cancer diagnosis and in-depth mutation profiling. |